News

The first of these agreements is focused on the development of methodologies to identify and quantify certain cell types circulating in blood that are potentially valuable biomarkers for

The researchers hope that the new drug will not suffer from the same kind of resistance problems as current treatments and, thanks to the grant, should be able

The results of the study, which are published in the Journal of Biological Psychiatry, showed that patients who received Corlux were more likely than patients who received placebo

The cell types are hepatocytes for the treatment of liver failure and osteoblasts and chondrocytes for the treatment of musculoskeletal disorders, including osteoarthritis, bone fractures and osteoporosis. The

Much has been written about the increasing number of children taking drugs for ADHD. One study found that the percentage of elementary school children taking medication for ADHD

The special protocol assessment (SPA) letter documents the agreement between FDA and BioCryst regarding the trial design’s suitability to support regulatory approval. The multicenter, open-label, nonrandomized, repeat-dose pivotal

Taisho, headquartered in Tokyo, granted Lilly exclusive rights for development and commercialization of TS-021 worldwide except for Japan and China under a license agreement executed in July 2005.

A team of US researchers found that these so-called ‘DES daughters’ aged over age 40 had 1.9 times the risk of developing breast cancer, compared to unexposed women

The primates in the trial achieved the improved glycemic control after treatment with MicroIslet’s proprietary microencapsulated porcine islet transplantation treatment approach. Primates in the trial showed substantial reduction